Implementation of a protocol using ketamine-propofol (‘ketofol’) in a 1 to 4 ratio for procedural sedation in adults at a university hospital emergency department – report on safety and effectiveness

ABSTRACT

Objectives: To test the feasibility of an evidence-based protocol for procedural sedation in adults at our emergency department, using a mixture of ketamine and propofol (‘ketofol’) in a 1 to 4 ratio. We hypothesize that the protocol is safe and effective and can facilitate procedural sedation.

Methods: During 14 months, adults in need of procedural sedation at our university hospital emergency department were included in a prospective convenience sample study. Patients with important comorbidity were discussed with the anaesthesiology department for feasibility of sedation in the emergency department setting. Outcome measures were procedural success, respiratory and hemodynamic events, vomiting, agitation or hallucinations, recall and physician’s satisfaction.

Results: Sixty-one patients between 18 and 89 years were included. All but one procedure were successful. Six respiratory events were registered in 6 patients (9.8%). These consisted of airway obstruction alleviated by airway repositioning and without influence on vital signs except for one brief episode of desaturation. Neither hemodynamic events nor vomiting were reported. Five patients (8.2%) experienced pleasant hallucinations and one patient (1.6%) became agitated upon awakening but recovered rapidly without medication. Three patients (4.9%) had recall and physician satisfaction rate was 93.4%.

Conclusion: A feasibility trial of an implemented protocol for ketofol procedural sedation in adults showed only minor respiratory events, a low incidence of agitation or hallucinations, minimal recall and a high success and physician satisfaction rate. Despite a non-consecutive and limited sample used, ketofol in a 1 to 4 ratio appears safe and effective for use in the emergency department.

KEYWORDS:

• Procedural sedation
• ketofol
• ketamine
• propofol
• emergency department

Disclosure statement

The authors report no conflict of interest.

Trial registration

At clinicaltrials.gov with ID number NCT04028141: https://clinicaltrials.gov/ct2/show/NCT04028141

Supplementary material

Supplemental data for this article can be accessed here.